CN108165565A - Mycobacterium tuberculosis H37Rv encoding gene and its application - Google Patents
Mycobacterium tuberculosis H37Rv encoding gene and its application Download PDFInfo
- Publication number
- CN108165565A CN108165565A CN201711251282.2A CN201711251282A CN108165565A CN 108165565 A CN108165565 A CN 108165565A CN 201711251282 A CN201711251282 A CN 201711251282A CN 108165565 A CN108165565 A CN 108165565A
- Authority
- CN
- China
- Prior art keywords
- mycobacterium tuberculosis
- encoding gene
- gene
- sequence
- tuberculosis h37rv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The present invention relates to a kind of Mycobacterium tuberculosis H37Rv encoding genes, can be used as the standard gene of mycobacterium tuberculosis complex Molecular Identification, for the Molecular Identification and clinical detection of mycobacterium tuberculosis complex.
Description
Technical field
The present invention relates to genetic test fields, and in particular to pathogen species are identified.
Background technology
Mycobacterium tuberculosis (Mycobacterium tuberculosis, MTB) is to cause mankind pathogen lungy.
Each organ of whole body can be invaded, but using pulmonary tuberculosis to be most common.Tuberculosis is infectious disease particularly important so far, the serious threat mankind
Life and health.According to WHO, every year there are about 8,000,000 new cases generation, at least 3,000,000 people die of the disease.The clinical bacterium of MTB
Strain hardly possible cultivates, is slow-growing and other mycobacteria energy cross-infections, tuberculosis and other respiratory tract infection symptom difficulties are distinguished etc.
Feature brings great difficulty to clinical quick diagnosis and treatment.Therefore establish quick, accurate, special, sensitive, cheap knot
Core disease detection method is the prerequisite and clinical labororatory's mycobacteria detection faces of effective treatment, control tuberculosis sprawling
The new challenge faced and new task.
Mycobacterium tuberculosis complex (Mycobacterium tuberculosis complex, MTBC), including
M.tuberculosis、M.africanum、M.orygis、M.bovis、M.microti、M.canettii、M.caprae、
The mycobacterias monoid such as M.pinnipedii, M.suricattae, M.mungi, these species can cause people and other life
Body tuberculosis.Following three classes are broadly divided into the identification method of MTBC both at home and abroad at present:Traditional isolated culture;Molecular level is examined
It surveys (IS6110, restriction fragment length polymorphism analysis, multidigit point variable number repeated fragment polymorphism analysis etc.);Thalline into
Divide (aliphatic acid, mycolic acid) chromatogram analysis method.Though three classes method has the advantages of respective, also there is shortcoming, such as pass
System is separately cultured period length, and with thalline can to cultivate rate low;Molecular level detection at present is in terms of specificity, sensitivity and simplicity
It is still poorer;Drive member specificity analysis cost is higher, complicated for operation.
MTB H37Rv completed genome sequencing in 1998, were the earliest MTB bacterial strains for completing full figure sequencing.Since then, respectively
State researchers are tactful based on algorithm optimization, annotating software update, transcription group and proteomics etc., always in perfect, benefit
Fill H37Rv gene annotation databases.However, since MTB belongs to prokaryotes, due to prokaryotic gene group remarking technology in itself
Deficiency, in genome annotation still there may be annotation mistake (excessively annotation, genetic borders mistake and ORF starting, stop bit
Point mistake, alternative splicing, ribosomes displacement, leakage annotation), to deeply, accurately parse biological mechanism bring puzzlement.To solve
This problem, protein gene group (Proteogenomics) though have been used for the correction that H37Rv has annotated gene, however, high
Ratio false positive, routine techniques are difficult to annotation predictive genes, new gene verification, new gene functional analysis and its application etc.
The problem that the field is faced.Generally speaking, traditional mycobacterium tuberculosis complex (MTBC) identification strategy has period length, step
Suddenly the defects of cumbersome, specific and sensitivity is not high.H37Rv full-length genomes are annotated again further to improve, find H37Rv
It is middle to omit annotation gene, it is ensured that H37Rv full-length genomes omit annotation gene and its application technology in MTBC Molecular Identifications obtains
To effective protection, it is imperative to develop and use H37Rv new genes fast accurate mirror method for distinguishing in MTBC monoids.
Invention content
It is an object of the present invention to provide a kind of new encoding gene of Mycobacterium tuberculosis H37Rv, which is H37Rv
Leakage annotation encoding gene Rv2003 (- | 2249260-2249457 |), it can be used as mycobacterium tuberculosis complex bar code molecule
Label, for detecting mycobacterium tuberculosis complex, sequence is as shown in SEQ ID NO.1.
Other objects of the present invention include providing Specific PCR primers and the offer that can be used for expanding above-mentioned encoding gene
It is a kind of to detect or identify the detection method that whether there is mycobacterium tuberculosis complex in sample;The present invention also provides with above-mentioned volume
The application of the detection kit and said gene of code gene-correlation.
According to an aspect of the present invention, by comparing protein gene group investigative technique, it was found that one in H37Rv
It is difficult to by the albumen coded sequence of predictive genes software discovery, which can be effectively by MTBC and the other species differentiations belonged to
It comes.The gene is the omission annotation base of a mycobacterium tuberculosis (Mycobacterium tuberculosis H37Rv)
Cause, i.e. Rv2003 (- | 2249260-2249457 |), it is similar to M.tuberculosis Bir 105 after NCBI-BLASTP
Property be 100%, M.tuberculosis J09701920 similitudes be 98%, M.canettii RefSeq (WP_
041179674.1) similitude is 97%, other species similarities are below 77%, and functional annotation albumen is
Phosphoenolpyruvate synthase.It is studied through comparative genomics and finds that the gene order can be by mycobacterium tuberculosis
Other kinds of compound group's (MTBC) bacterial strain and Mycobacterium, which distinguish, to be come.
Specifically, design can realize that specific amplification draws to the Rv2003 of MTBC (- | 2249260-2249457 |) gene
Object, primer as proposed by the invention, primer sequence are:
F:5’-CCAACCATCACTGTCAGC-3’;
R:5’-AGCAACAATCGGCGTTC-3’。
The difference of the presence or absence of gene DNA sequence PCR product in sample to be tested or DNA sequence dna, can be quickly accurate
True identification of M TBC.
According to another aspect of the present invention, based on the new standard code gene of above-mentioned Mycobacterium tuberculosis H37Rv, this hair
The bright method for specifically establishing detection or identifying mycobacterium tuberculosis complex, step are as follows:
(1) the separation and Extraction genomic DNA from sample to be tested;
(2) DNA obtained using step (1) carries out PCR amplification as template using following primer:
F:5’-CCAACCATCACTGTCAGC-3’(SEQ ID NO.4);
R:5’-AGCAACAATCGGCGTTC-3’(SEQ ID NO.5)。
(3) DNA product obtained to step (2) amplification carries out gel electrophoresis analysis or is sequenced;
(4) result of step (3) and bar code gene Rv2003 (- | 2249260-2249457 |) are compared, if
Homology is more than 99%, and judgement sample to be tested contains mycobacterium tuberculosis complex.
Further, above-mentioned detection method according to DNA bar code principle, tentatively carries out electrophoretic analysis, such as to PCR product
Fruit strain to be tested does not have target stripe, and it is not MTBC to illustrate the bacterial strain;If there is band, then can further sequence verification, will survey
The standard sequence that sequence obtains series and the Rv2003 of H37Rv (- | 2249260-2249457 |) carries out Homology search and comparison, obtains
The similitude between sequence is obtained, if sequence homology is more than 99%, you can judgement bacterial strain may be MTBC;According to identification bacterium to be identified
The DNA bar code sequence of strain and standard sequence cluster situation are common to distinguish MTBC families and non-tuberculous mycobacteria, respiratory tract
Pathogen and common respiratory tract virus.
The detection method can be used to the strain idenfication research to mycobacterium tuberculosis complex, it can also be used to clinical quick
It examines.Sample to be tested can be from H37Rv bacterial strains, other MTBC, non-tuberculous mycobacteria, respiratory tract encountered pathogenic bacteria, breathing
Road common virus bacterial strain;Either directly using tuberculosis and other respiratory tract patient sputums, saliva or blood.
Based on the above method, the present invention also provides detection kit, and kit containers are built-in to detect knot
The reagent of standard code gene new core mycobacteria H37Rv, what is concurrently provided can be through governmental drug management organization
Manufacture, use and sales informations audit, in relation to drug or biological products.For example, after using PCR amplification, sample is directly detected
The reagent of Rv2003 in product (- | 2249260-2249457 |) gene, such as amplimer, dNTP can be contained, reacted for PCR
Archaeal dna polymerase and its buffer solution, endonuclease reaction and/or reagent needed for sequencing reaction etc. it is one or more.Art technology
Personnel are it is known that more than component is only illustrative, for example, above-mentioned Specific PCR primers, the use may be used in the primer
The enzyme of PCR amplification is can be used in the archaeal dna polymerase of PCR reactions.The detection of the encoding gene of the present invention can also be with integrated
The mode of such as genetic chip provide.
Advantageous effect:The present invention provides one kind to be used as mycobacterium tuberculosis complex (Mycobacterium
Tuberculosis complex, MTBC) Molecular Identification standard gene and method for identifying molecules, the gene can effectively by
MTBC comes with the other species differentiations belonged to, and existing mycobacterium tuberculosis complex is overcome using the identification method of the gene
The shortcomings of design of primers multiplicity in qualification process, result poor repeatability, has the characteristics that general, easy amplification, easily compares, can
Accurately to identify to come from the close other mycobacterias of affiliation or other respiratory tract infection germs by the monoid, it is
Tuberculosis epidemiological survey and clinical tuberculosis patient quick diagnosis differentiate the strong technological means of offer and research tool.
Description of the drawings
Fig. 1:Support the peptide spectrum matching evidence of the newly encoded gene found;
Fig. 2:Section of synthesized peptide mass spectrogram is compared with former identification peptide fragment mass spectrogram;
Fig. 3:Peptide fragment is located the protein sequence corresponding diagram of region ORF codings;It is identified for proteomics underscore part
And it is synthesized the peptide fragment of peptide fragment verification;
Fig. 4:Rv2003 (- | 2249260-2249457 |) standard gene sequence homology compares;
Fig. 5:Protein sequence BLASTP knots corresponding to H37Rv bacterial strains Rv2003 (- | 2249260-2249457 |) gene
Fruit;
Fig. 6:Rv2003 (- | 2249260-2249457 |) specific primer PCR amplified production agarose gel electrophoresis result;
Wherein, each Lane Sample information is shown in Table 1.
Fig. 7:Rv2003 (- | 2249260-2249457 |) gene PCR expands sequencing result and standard sequence compares.
Specific embodiment
The present invention will be further described With reference to embodiment, but does not limit scope of the invention as claimed.
Agents useful for same of the present invention is commercially available.
Embodiment 1:Find the leakage annotation encoding gene of H37Rv strain gene groups
The high covering protein group verification of 1.1 pairs of H37Rv strain gene groups
The depth that protein group has been carried out to H37Rv bacterial strains using high covering protein technique covers research.It is based on
Tuberculosis (20160307) database has carried out its genome using 3 engines of pFind the verification of annotation encoding gene.
In order to find new protein-coding region, we are based on protein gene omics technology, and H37Rv is sent out in NCBI with pAnno softwares
Full-length genome (NC_000962.3) file of table carries out six reading frame data base interpretations, and using this database to spectra count
According to the identification for having carried out new peptide fragment and novel protein.In order to reduce false positive rate, we have used 3 during data filtering
Kind separately estimates the filter method of classification FDR to having annotated peptide fragment and new peptide fragment, is S-FDR, T-FDR I and T-FDR respectively
II。
Through data analysis, we identify 3238 H37Rv and have annotated gene altogether, coverage be up to the 80% of the bacterial strain with
On, this is to report maximum H37Rv protein spectrum data so far.In addition, after being filtered through 3 kinds of FDR≤1, we obtain new peptide fragment.
In order to further ensure that new peptide fragment quality, the spectrogram corresponding to our new peptide fragments remaining to above-mentioned filtering has carried out spectrogram quality
Screening, finally remains the high-quality peptide fragment of some spectrograms.For further investigate the higher peptide fragment of these spectrogram quality not by
Caused by having annotated peptide fragment and single amino acids mutation occurs, We conducted amino acid mutation verifications, it is ensured that these new peptide fragments are
H37Rv newly identifies peptide fragment.
The coding albumen and database authentication of 1.2 couples of Rv2003 (- | 2249260-2249457 |) gene
After excessively high covering protein group verification, it has been found that some doubtful new leakage annotation peptide fragments, it can to above-mentioned height
Doubtful new peptide fragment progress peptide fragment synthesis verification is believed to obtain, according to new peptide fragment original spectrum and peptide fragment synthesis spectrum similarity >=0.8 conduct of marking
Similarity threshold after marking is screened, has several peptide fragments by verification, corresponding to new open reading frame (Open Reading
Frame, ORF), i.e., the potential leakage annotation gene of current H37Rv bacterial strains.
Wherein, it has been found that new leakage annotation gene Rv2003 (- | 2249260-2249457 |), compare through BLASTP, with
105 similitudes of M.tuberculosis Bir are that 100%, M.tuberculosis J09701920 similitudes are 98%,
The similitude of M.canettii RefSeq (WP_041179674.1) is 97%, and other species similarities are below 77%, work(
It is Phosphoenolpyruvate synthase that albumen, which can be annotated,.We detect peptide fragment
MGITSVSVHSGAIAATPGSVAAAER (SEQ ID NO.6), and corresponding to new gene Rv2003 (- | 2249260-2249457
|), as shown in Figure 1, spectrogram quality is fine, there are continuous 5 b/y ion continuous couplings, miscellaneous peak signal is relatively low, as a result very credible.
Further to confirm this qualification result, we newly identify that the amino acid sequence chemistry of peptide fragment is synthesized according to us
The peptide fragment, and produce using above-mentioned mass spectral analysis condition the two level spectrogram of the section of synthesized peptide.
The high energy collision MS that we generate section of synthesized peptide2It is verified, level-one parent ion and two level daughter ion are equal
Meet theoretical value, show that the peptide section sequence that we synthesize is correct;On this basis, we are had checked according to large-scale protein by hand
The MS of the section of synthesized peptide of new peptide section sequence that matter group data authentication arrives2With the new peptide fragment spectrogram of Large scale identification, the two is almost
The one cosin values for showing the acquisition of daughter ion similitude are 0.87, it was demonstrated that the correct nothing of new peptide fragment that we identify from H37Rv
Accidentally.(Fig. 2).
After the sequence for confirming above-mentioned leakage annotation peptide fragment, according to the gene location where above-mentioned peptide fragment, with previous termination
The region that codon and the latter terminator codon include is boundary, obtains including the open reading frame of above-mentioned new leakage annotation peptide fragment
(ORF) DNA sequence dna, as shown in SEQ ID NO.2.
TGAGCGCTCCGTGGGACAGGCCTACCACATCTGGCGCAGCGCGATCTGAGAACGCCGAAAGGAAAACCGATGCCAAC
CATCACTGTCAGCAGCACATCGTCGCTGTGTGGTCAAGCGCTCTCGGGCAACCCGACTTTCGCCGAGCATCTGGTCC
GGATGGGAATCACCTCAGTGTCGGTCCATTCGGGCGCGATTGCTGCTACCCCGGGGTCGGTCGCGGCCGCCGAACGC
CGATTGTTGCTGGAATCAGCTCGCGGTGACGCCTGA(SEQ ID NO.2)
Open reading frame coding is as shown in Figure 3 with the correspondence of amino acid sequence.
Further translation verification, finds true gene order (SEQ ID NO.1) from above-mentioned open reading frame DNA (SEQ
ID NO.2) inATGStart, common 198bp, 65 amino acid of coding, theoretical molecular weight 6.51kDa, as Rv2003 (- |
2249260-2249457 |) gene.
ATGCCAACCATCACTGTCAGCAGCACATCGTCGCTGTGTGGTCAAGCGCTCTCGGGCAACCCGACTTTCGCCGAGCA
TCTGGTCCGGATGGGAATCACCTCAGTGTCGGTCCATTCGGGCGCGATTGCTGCTACCCCGGGGTCGGTCGCGGCCG
CCGAACGCCGATTGTTGCTGGAATCAGCTCGCGGTGACGCCTGA(SEQID NO.1)
The gene theory coded product amino acid sequence is as shown in SEQ ID NO.3:
MPTITVSSTSSLCGQALSGNPTFAEHLVRMGITSVSVHSGAIAATPGSVAAAERRLLLESARGDA(SEQ
ID NO.3)
NCBI-BLASTP analyses are carried out to the amino acid sequence of gene encoding production theoretical shown in the SEQ ID NO.3, with
105 similitudes of M.tuberculosis Bir are that 100%, M.tuberculosis J09701920 similitudes are 98%,
The similitude of M.canettii RefSeq (WP_041179674.1) is 97%, and other species similarities are below 77%, work(
It is Phosphoenolpyruvate synthase that albumen, which can be annotated, (see Fig. 4).Show Rv2003 that we detect (- |
2249260-2249457 |) gene outcome is missed annotation in H37Rv bacterial strain databases.
The DNA sequence dna of the Rv2003 (- | 2249260-2249457 |) gene is compared genome local by us
BLAST is analyzed, as shown in Figure 5, the results showed that Rv2003 (- | 2249260-2249457 |) gene order belongs to MTBC families spy
Specific gene, the sequence for not having homology higher in other species, this shows the Rv2003 that we have found in H37Rv bacterial strains
(- | 2249260-2249457 |) gene order has preferable sequence-specific, MTBC and it can will belong to interior other mycobacterias
And other Bacteria infecting respiratories distinguish.
Embodiment 2:The method for establishing the compound groups of identification of M TBC
(1) primer is designed:
Based on the CDS sequences of Rv2003 (- | 2249260-2249457 |) gene as shown in SEQ ID NO.1, use
Oligo7.0 devises PCR primer, and primer sequence is as follows:
F:5’-CCAACCATCACTGTCAGC-3’(SEQ ID NO.4);
R:5’-AGCAACAATCGGCGTTC-3’(SEQ ID NO.5)
Above-mentioned primer is as follows with the position relationship of Rv2003 (- | 2249260-2249457 |) gene, wherein primer
Corresponding position subscript list is crossed.
ATGCCAACCATCACTGTCAGCAGCACATCGTCGCTGTGTGGTCAAGCGCTCTCGGGCAACCCGACTTTC
GCCGAGCATCTGGTCCGGATGGGAATCACCTCAGTGTCGGTCCATTCGGGCGCGATTGCTGCTACCCCGGGGTCGGT
CGCGGCCGCCGAACGCCGATTGTTGCTGGAATCAGCTCGCGGTGACGCCTGA
(SEQ ID NO.1)
(2) total DNA of strain to be tested of the extraction including M.tuberculosis H37Rv, 40 plants of Mycobacterium marks
For quasi- bacterial strain by Chinese medicine bacteria culture preservation administrative center (CMCC) preservation, remaining 16 plants of non-tuberculous mycobacteria is Chinese
309 hospital clinical separation strains of people's liberation army have completed strain 16SRNA gene sequencing, comparison and NCBI sequences and have submitted work,
Strain to be tested is as shown in table 1:
The related strain that table 1. is selected
(3) amplification of DNA fragments carries out polymerase chain (PCR) and reacts, and above-mentioned F/R primers used are expanded.
PCR system (25 μ L) is ddH2O (9.5 μ L), 2XTaq PCR MasterMix (TIANGEN, 12.5 μ L) primers F
(10 μM, 1 μ L), primer R (10 μM, 1 μ L), DNA profiling (1 μ L);
Amplification program:94 DEG C of pre-degeneration 3min, 94 DEG C denaturation 30s, 58 DEG C annealing 30s, 72 DEG C extension 1min, 35 follow
Ring, 72 DEG C of extension 5min.
(4) amplified production electrophoresis detection, the electrophoresis detection in Ago-Gel, 1 × TBE electrophoresis liquids.As a result such as Fig. 6 institutes
Show, MTBC and control group amplified band occur, and practical amplification is consistent with expection at 170bp, and specificity is
98.3%.
(5) in order to further verify the sequence of the DNA of amplification, we have carried out extension increasing sequence sequencing and and former sequence ratio
Compared with as shown in fig. 7, result is consistent completely with expection, sequence is correct, this further demonstrates depositing for new leakage annotation gene
.
This shows that the method that the compound group's identifications of MTBC are carried out based on Rv2003 (- | 2249260-2249457 |) gene is true
Reliably.
SEQUENCE LISTING
<110>Beijing Proteome Research Center
<120>Mycobacterium tuberculosis H37Rv encoding gene and its application
<130> BJ1936-17P121796
<160> 6
<170> PatentIn version 3.3
<210> 1
<211> 198
<212> DNA
<213> Artificial
<220>
<223>Mycobacterium tuberculosis H37Rv encoding gene Rv2003 (- | 2249260-2249457 |)
<400> 1
atgccaacca tcactgtcag cagcacatcg tcgctgtgtg gtcaagcgct ctcgggcaac 60
ccgactttcg ccgagcatct ggtccggatg ggaatcacct cagtgtcggt ccattcgggc 120
gcgattgctg ctaccccggg gtcggtcgcg gccgccgaac gccgattgtt gctggaatca 180
gctcgcggtg acgcctga 198
<210> 2
<211> 267
<212> DNA
<213> Artificial
<220>
<223>Include the open reading frame DNA sequence dna of leakage annotation peptide fragment
<400> 2
tgagcgctcc gtgggacagg cctaccacat ctggcgcagc gcgatctgag aacgccgaaa 60
ggaaaaccga tgccaaccat cactgtcagc agcacatcgt cgctgtgtgg tcaagcgctc 120
tcgggcaacc cgactttcgc cgagcatctg gtccggatgg gaatcacctc agtgtcggtc 180
cattcgggcg cgattgctgc taccccgggg tcggtcgcgg ccgccgaacg ccgattgttg 240
ctggaatcag ctcgcggtga cgcctga 267
<210> 3
<211> 65
<212> PRT
<213> Artificial
<220>
<223>Rv2003 (- | 2249260-2249457 |) gene theory coded product amino acid sequence
<400> 3
Met Pro Thr Ile Thr Val Ser Ser Thr Ser Ser Leu Cys Gly Gln Ala
1 5 10 15
Leu Ser Gly Asn Pro Thr Phe Ala Glu His Leu Val Arg Met Gly Ile
20 25 30
Thr Ser Val Ser Val His Ser Gly Ala Ile Ala Ala Thr Pro Gly Ser
35 40 45
Val Ala Ala Ala Glu Arg Arg Leu Leu Leu Glu Ser Ala Arg Gly Asp
50 55 60
Ala
65
<210> 4
<211> 18
<212> DNA
<213> Artificial
<220>
<223>F primer sequences
<400> 4
ccaaccatca ctgtcagc 18
<210> 5
<211> 17
<212> DNA
<213> Artificial
<220>
<223>R primer sequences
<400> 5
agcaacaatc ggcgttc 17
<210> 6
<211> 25
<212> PRT
<213> Artificial
<220>
<223>Leakage annotation peptide fragment
<400> 6
Met Gly Ile Thr Ser Val Ser Val His Ser Gly Ala Ile Ala Ala Thr
1 5 10 15
Pro Gly Ser Val Ala Ala Ala Glu Arg
20 25
Claims (10)
1. a kind of Mycobacterium tuberculosis H37Rv encoding gene, the nucleotide sequence such as SEQ ID NO.1 institutes of the encoding gene
Show.
2. Mycobacterium tuberculosis H37Rv encoding gene described in claim 1, it is characterised in that the gene code such as SEQ ID
Amino acid shown in NO.3 sequences.
3. a kind of bar code molecular labeling, as detecting and/or identifying mycobacterium tuberculosis complex, it includes examined as standard
The Mycobacterium tuberculosis H37Rv encoding gene described in claim 1 of cls gene.
A 4. species-specific PCR primers, for expanding Mycobacterium tuberculosis H37Rv encoding gene described in claim 1.
5. the PCT primers described in claim 4, which is characterized in that the sequence of the primer is:
F:5’-CCAACCATCACTGTCAGC-3’;
R:5’-AGCAACAATCGGCGTTC-3’。
6. a kind of detection method of mycobacterium tuberculosis complex identification, includes the following steps:
(1) the separation and Extraction genomic DNA from sample to be tested;
(2) DNA obtained using step (1) adds in amplimer as template, carries out PCR;
(3) DNA product obtained to step (2) amplification carries out gel electrophoresis analysis or is sequenced;
(4) result of step (3) is compared with encoding gene described in claim 1, it is to be measured according to its homologous sex determination
It whether there is mycobacterium tuberculosis complex in sample.
7. the amplimer sequence described in the detection method described in claim 6, wherein step (2) is:
F:5’-CCAACCATCACTGTCAGC-3’;
R:5’-AGCAACAATCGGCGTTC-3’。
8. the detection method described in claim 6, wherein in step (4), if homology is more than 99%, test sample is treated in judgement
Contain mycobacterium tuberculosis complex in product.
9. a kind of detection kit, will comprising Mycobacterium tuberculosis H37Rv encoding gene described in claim 1 and/or right
Seek the Specific PCR primers described in 4.
10. Mycobacterium tuberculosis H37Rv encoding gene described in claim 1 is in tuberculosis epidemiological survey and/or clinical knot
Application in core patient quick diagnosis and discriminating.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711251282.2A CN108165565B (en) | 2017-12-01 | 2017-12-01 | Mycobacterium tuberculosis H37Rv encoding gene and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711251282.2A CN108165565B (en) | 2017-12-01 | 2017-12-01 | Mycobacterium tuberculosis H37Rv encoding gene and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108165565A true CN108165565A (en) | 2018-06-15 |
CN108165565B CN108165565B (en) | 2021-04-20 |
Family
ID=62525094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711251282.2A Active CN108165565B (en) | 2017-12-01 | 2017-12-01 | Mycobacterium tuberculosis H37Rv encoding gene and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108165565B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110343706A (en) * | 2019-01-25 | 2019-10-18 | 北京蛋白质组研究中心 | Mycobacterium tuberculosis H37Rv encoding gene and its application |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1715422A (en) * | 2004-06-30 | 2006-01-04 | 中国农业科学院哈尔滨兽医研究所 | Novel Mycobacterium bovis and the method for quick identification of mycobacterium tuberculosis and application |
CN103014135A (en) * | 2011-09-22 | 2013-04-03 | 上海市肺科医院 | Method for identifying mycobacterium tuberculosis |
-
2017
- 2017-12-01 CN CN201711251282.2A patent/CN108165565B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1715422A (en) * | 2004-06-30 | 2006-01-04 | 中国农业科学院哈尔滨兽医研究所 | Novel Mycobacterium bovis and the method for quick identification of mycobacterium tuberculosis and application |
CN103014135A (en) * | 2011-09-22 | 2013-04-03 | 上海市肺科医院 | Method for identifying mycobacterium tuberculosis |
Non-Patent Citations (3)
Title |
---|
GENBANK: "WP_003410051", 《GENGBANK》 * |
毛欣茹 等: "建立基于gyrB 基因检测结核分枝杆菌复合物的荧光定量PCR法", 《临床检验杂志》 * |
赵加玲 等: "结核分枝杆菌H37Rv 新基因Rv2742 克隆表达及纯化", 《生物工程学报》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110343706A (en) * | 2019-01-25 | 2019-10-18 | 北京蛋白质组研究中心 | Mycobacterium tuberculosis H37Rv encoding gene and its application |
Also Published As
Publication number | Publication date |
---|---|
CN108165565B (en) | 2021-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ikryannikova et al. | Discrimination between Streptococcus pneumoniae and Streptococcus mitis based on sorting of their MALDI mass spectra | |
JP5317430B2 (en) | Probe set, probe carrier, and fungal discrimination identification method | |
Ikryannikova et al. | Misidentification of alpha-hemolytic streptococci by routine tests in clinical practice | |
CN109182517B (en) | Gene for molecular typing of medulloblastoma and application thereof | |
CN113881789B (en) | Probe and primer pair composition for detecting cryptococcus and detection method and application | |
US20140162260A1 (en) | Primers, snp markers and method for genotyping mycobacterium tuberculosis | |
CN115976235B (en) | Identification method of Lactobacillus delbrueckii CICC6047 strain, and primer, kit and application thereof | |
CN110408629A (en) | Mycobacterium tuberculosis H37Rv encoding gene and its application | |
CN110408630A (en) | Mycobacterium tuberculosis H37Rv encoding gene and its application | |
CN106811530A (en) | Kit and primer based on HRM technology for detection Drug Resistance of Mycobacterium Tuberculosis | |
CN108165562A (en) | Mycobacterium tuberculosis H37Rv encoding gene and its application | |
CN108004253A (en) | Mycobacterium tuberculosis H37Rv encoding gene and its application | |
CN105420392B (en) | One group of gene new mutation relevant to newborn's Tendon defection phenotype and detection kit | |
CN108165561A (en) | Mycobacterium tuberculosis H37Rv encoding gene and its application | |
CN108165565A (en) | Mycobacterium tuberculosis H37Rv encoding gene and its application | |
CN108165564A (en) | Mycobacterium tuberculosis H37Rv encoding gene and its application | |
CN108165560A (en) | Mycobacterium tuberculosis H37Rv encoding gene and its application | |
CN110408632A (en) | Mycobacterium tuberculosis H37Rv encoding gene and its application | |
CN108165563A (en) | Mycobacterium tuberculosis H37Rv encoding gene and its application | |
Salehi et al. | Internal Transcribed Spacer rDNA and TEF-1α Gene Sequencing of Pathogenic Dermatophyte Species and Differentiation of Closely Related Species Using PCR-RFLP of The Topoisomerase II | |
CN110408631A (en) | Mycobacterium tuberculosis H37Rv encoding gene and its application | |
CN110343706A (en) | Mycobacterium tuberculosis H37Rv encoding gene and its application | |
CN110106276A (en) | A kind of kit and discrimination method identifying Radix Angelicae Sinensis | |
KR100568702B1 (en) | DNA microarray for species identification of microorganism and its manufacture method | |
CN113174443B (en) | Mycobacterium identification method and biological material thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230613 Address after: 100850 No. 27 Taiping Road, Beijing, Haidian District Patentee after: ACADEMY OF MILITARY MEDICAL SCIENCES Address before: Building 1, No.33, kekeyuan Road, Changping District, Beijing Patentee before: BEIJING PROTEOME RESEARCH CENTER |
|
TR01 | Transfer of patent right |